New Patient-Oriented Tools for Assessing Atrophic Acne Scarring

Area of Science:

• Dermatology
• Patient-Reported Outcomes
• Psychological Impact of Skin Conditions

Background:

• Facial acne scarring significantly impacts patients' lives and psychological well-being.
• Current assessment tools lack patient-reported measures for acne scarring severity and treatment benefit.
• Validated instruments are needed to capture the patient perspective on atrophic acne scarring.

Purpose of the Study:

• To develop and validate patient-reported outcome measures for atrophic acne scarring.
• To create tools assessing both the physical symptoms and the psychological/social impact of facial acne scars.
• To establish instruments suitable for clinical research settings and rapid patient completion.

Main Methods:

• Development of two tools: Self-Assessment of Clinical Acne-Related Scars (SCARS) and Facial Acne Scar Quality of Life (FASQoL).
• Methodology followed Food and Drug Administration guidance, including concept elicitation and cognitive interviews with patients.
• Tools designed for self-completion, focusing on patient-important concepts like scar size, count, and depth, and psychological well-being.

Main Results:

• Concept elicitation and cognitive interviews confirmed patient-important concepts related to acne scarring.
• The developed SCARS and FASQoL tools effectively capture relevant concepts and are easily understood by patients.
• Initial validation indicates the tools address key aspects of the acne scarring experience from the patient's viewpoint.

Conclusions:

• The SCARS and FASQoL tools provide validated, patient-centered measures for atrophic acne scarring.
• These instruments can aid clinicians in assessing acne scar severity and impact.
• Further evaluation is required to determine the responsiveness of these measures to treatment interventions.